Buy Like Buffett
Watchlist

Flagship explainer

What drives AKEBIA THERAPEUTICS, INC.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity64%Tax burden144%net income ÷ pretax incomeInterest burden−16%pretax ÷ operating incomeOperating margin10%operating income ÷ revenueAsset turnover0.79×revenue ÷ average assetsEquity multiplier-36.03×average assets ÷ average equityAs of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
−$5.3MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001517022-26-000020 · filed Feb 26, 2026
Income before tax−$3.7MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001517022-26-000020 · filed Feb 26, 2026
Operating income$23.5MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001517022-26-000020 · filed Feb 26, 2026
$236MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001517022-26-000020 · filed Feb 26, 2026
Ending assets$377MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001517022-26-000020 · filed Feb 26, 2026
Beginning assets$221MFY2024
  • 10-K · FY 2024Filing detailsAccession 0001517022-26-000020 · filed Feb 26, 2026
$32.6MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001517022-26-000020 · filed Feb 26, 2026
−$49.2MFY2024
  • 10-K · FY 2024Filing detailsAccession 0001517022-26-000020 · filed Feb 26, 2026
Source: · event Dec 31, 2025 · retrieved Oct 17, 2026 · annual-row source set
Embed this chart

View the full AKEBIA THERAPEUTICS, INC. analysis at Buy Like Buffett

AKBA dupont explainer — Buy Like Buffett · Buy Like Buffett